These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8852514)

  • 21. T-cell receptor constant beta germline gene polymorphisms and susceptibility to autoimmune hepatitis.
    Manabe K; Hibberd ML; Donaldson PT; Underhill JA; Doherty DG; Demaine AG; Mieli-Vergani G; Eddleston AL; Williams R
    Gastroenterology; 1994 May; 106(5):1321-5. PubMed ID: 7909781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of multiple restriction fragment length polymorphisms of the gene for the human complement receptor type I. Duplication of genomic sequences occurs in association with a high molecular mass receptor allotype.
    Wong WW; Kennedy CA; Bonaccio ET; Wilson JG; Klickstein LB; Weis JH; Fearon DT
    J Exp Med; 1986 Nov; 164(5):1531-46. PubMed ID: 2877046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
    Kouki T; Gardine CA; Yanagawa T; Degroot LJ
    J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A C/T polymorphism in the 5' untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese.
    Mukai T; Hiromatsu Y; Fukutani T; Ichimura M; Kaku H; Miyake I; Yamada K
    Endocr J; 2005 Aug; 52(4):471-7. PubMed ID: 16127217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus.
    Garcia-Ameijeiras A; Gladman DD; Chan JY; Volpé R
    Clin Invest Med; 1993 Oct; 16(5):326-32. PubMed ID: 7903231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of class II DNA restriction fragments with responsiveness to Ambrosia artemisiifolia (short ragweed)-pollen allergen Amb a V in ragweed-allergic patients.
    Zwollo P; Ansari AA; Marsh DG
    J Allergy Clin Immunol; 1989 Jan; 83(1):45-54. PubMed ID: 2563269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of polymorphic variants of IL-1β and IL-1RN genes in the development of Graves' disease in Kashmiri population (North India).
    Shehjar F; Afroze D; Misgar RA; Malik SA; Laway BA
    Hum Immunol; 2018 Apr; 79(4):228-232. PubMed ID: 29454070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of a T-cell receptor constant alpha chain gene polymorphism with progression of IgA nephropathy in Japanese patients.
    Deenitchina SS; Shinozaki M; Hirano T; Ando T; Hirakata H; Kiyohara Y; Katafuchi R; Fujishima M
    Am J Kidney Dis; 1999 Aug; 34(2):279-88. PubMed ID: 10430975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allelic sequence variations in the hypervariable region of a T-cell receptor beta chain: correlation with restriction fragment length polymorphism in human families and populations.
    Robinson MA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9422-6. PubMed ID: 2574461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-13 gene polymorphisms in patients with Graves' disease.
    Bednarczuk T; Placha G; Jazdzewski K; Kurylowicz A; Kloza M; Makowska U; Hiromatsu Y; Nauman J
    Clin Endocrinol (Oxf); 2003 Oct; 59(4):519-25. PubMed ID: 14510917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism in human T cell receptor alpha chain variable region genes.
    Grier AH; Mitchell MP; Robinson MA
    Exp Clin Immunogenet; 1990; 7(1):34-42. PubMed ID: 1971756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTLA-4 gene A-G polymorphism and childhood Graves' disease.
    Yung E; Cheng PS; Fok TF; Wong GW
    Clin Endocrinol (Oxf); 2002 May; 56(5):649-53. PubMed ID: 12030917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis.
    Kunikane H; Abe S; Yamaguchi E; Aparicio JM; Wakisaka A; Yoshiki T; Kawakami Y
    Thorax; 1994 Jun; 49(6):573-6. PubMed ID: 7912453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PVU II polymorphism of LST-1 (leucocyte specific transcript-1) in type I diabetes mellitus, Graves' disease and healthy controls.
    Rau H; Usadel KH; Ommert S; Badenhoop K
    Eur J Immunogenet; 1995 Jun; 22(3):277-82. PubMed ID: 8547234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyrotoxic periodic paralysis; a reversible cause of paralysis to remember.
    Akhter J; Weide LG
    S D J Med; 1997 Oct; 50(10):357-8. PubMed ID: 9360442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restriction fragment length polymorphism of the major histocompatibility complex of the dog.
    Sarmiento UM; Storb RF
    Immunogenetics; 1988; 28(2):117-24. PubMed ID: 2899546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
    Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implication of the HLA-DRB3 gene in Graves' disease: predominance of allele Dw24.
    Semana G; Allanic H; Quillivic F; Vallejo MT; Simon JP; Genetet B; Fauchet R
    Hum Immunol; 1990 Oct; 29(2):143-9. PubMed ID: 1979072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conservation of the central MHC genome: PFGE mapping and RFLP analysis of complement, HSP70, and TNF genes in the goat.
    Cameron PU; Tabarias HA; Pulendran B; Robinson W; Dawkins RL
    Immunogenetics; 1990; 31(4):253-64. PubMed ID: 1970334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of immunoglobulin VH and TCR cbeta polymorphisms in a large family with thyroid autoimmune disorder.
    Fakhfakh F; Maalej A; Makni H; Abid M; Jouida J; Zouali M; Ayadi H
    Exp Clin Immunogenet; 1999; 16(4):185-91. PubMed ID: 10575272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.